Logo (WIPO, 03.01.2018)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke wurde als Bildmarke am 03.01.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Andere Polygone #Farben #Ein Polygon #Polygone, die ein oder mehrere Dreiecke oder Linien enthalten, die einen Winkel bilden (geben Sie den Inhalt an) #Polygone, die eine oder mehrere andere geometrische Figuren enthalten (geben Sie den Inhalt an) #Zwei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1408354 |
| Länder | 
|
| Basismarke |
Nr. 87565885,
11. August 2017
|
| Anmeldedatum | 03. Januar 2018 |
| Ablaufdatum | 03. Januar 2028 |
Markeninhaber
8717 W 110th Street, Suite 300
Overland Park KS 66210
US
Overland Park KS 66210
US
Markenvertreter
10801 Mastin Blvd., Suite 1000
Overland Park KS 66210
US
Waren und Dienstleistungen
35
Business information and business consulting services,
namely, providing business advisory services to identify,
screen, and select contract manufacturing organizations to
contract and build medical and pharmaceutical products and
devices; providing business advisory services to health care
providers, namely, designing the administrative, financial
and clinical workflows associated with value-based
healthcare delivery models; providing business assistance to
healthcare providers in the field of enabling communication
and collaboration for the purpose of developing,
implementing and evaluating patient care plans; business
services, namely, tracking and monitoring regulatory
requirements in the pharmaceutical, biotechnology, and
medical fields for business purposes; maintaining files and
records concerning the medical condition of individuals;
maintaining personal medical history records and files;
business consulting services in the medical, pharmaceutical,
and biotechnology fields
42
Providing quality assurance services in the medical,
pharmaceutical, and biotechnology fields; quality management
services, namely, quality evaluation and analysis, quality
assurance, and quality control, in the medical,
pharmaceutical, and biotechnology fields; testing, analysis,
and evaluation of medical, pharmaceutical, and biotechnology
services to assure compliance with industry standards;
tracking and monitoring regulatory requirements in the
pharmaceutical, biotechnology, and medical fields for
quality control purposes; consulting services in the
biotechnology field
44
Consulting services in the medical and pharmaceutical
fields; providing medical and pharmaceutical information
services, namely, drug interaction call centers, adverse
event reporting services for drugs and medical devices and
product compliant reporting services for drugs and medical
device; medical information; providing medical information,
consultancy and advisory services; health care consulting,
namely, aggregating clinical, claims, socioeconomic and
behavioral health data for the purpose of improving
healthcare providers' evaluation of health conditions and
health risks with individual patients, cohorts of patients,
and populations; health care consulting, namely, assessing
patient and population health profiles using evidence-based
medical guidelines for the purpose of improving healthcare
provider treatment decisions at the point of care; providing
information over a global computer network in the field of
health care; providing medical information, consultancy, and
advisory services, namely, providing healthcare providers,
insurance companies, and healthcare product manufacturers
with information and statistics regarding patient medication
intake, schedule compliance, and health status
45
Regulatory compliance consulting in the pharmaceutical,
biotechnology, and medical fields; regulatory compliance
consulting in the fields of drug and device development and
manufacturing; tracking and monitoring regulatory
requirements in the pharmaceutical, biotechnology, and
medical fields for legal or regulatory compliance purposes;
tracking and monitoring regulatory requirements in the field
of drug and device development and manufacturing for
regulatory compliance purposes
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 27. Januar 2021 | 2021/6 Gaz | RAW: Holder Rights Restriction | |
| 14. März 2019 | 2019/27 Gaz | JP | Ablehnung |
| 27. Februar 2019 | 2019/10 Gaz | CN | Ablehnung |
| 19. Februar 2019 | 2019/27 Gaz | AU | Ablehnung |
| 06. Februar 2019 | 2019/6 Gaz | GB | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 15. Januar 2019 | 2019/7 Gaz | CN | Ablehnung |
| 23. November 2018 | 2018/49 Gaz | EM | Ablehnung |
| 27. Juli 2018 | 2018/32 Gaz | GB | Ablehnung |
| 03. Januar 2018 | US | Eintragung |
ID: 141408354